C4 Therapeutics, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-049854
- Form type
- 10-Q
- CIK
- 0001662579
- Primary document
- https://www.sec.gov/Archives/edgar/data/1662579/000162828025049854/cccc-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for C4 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $24.9M | - | - |
| Operating Income | $-92.1M | - | - |
| Net Income | $-84.5M | - | - |
| Eps Basic | -1.18 | - | - |
| Eps Diluted | -1.18 | - | - |
| Cash And Equivalents | $58.8M | - | - |
| Total Assets | $265.5M | - | - |
| Total Liabilities | $111.1M | - | - |
| Shareholders Equity | $154.4M | - | - |
| Operating Cash Flow | $-76.5M | - | - |
| Capital Expenditures | $596,000 | - | - |